Inclusão digital e educação para a competência informacional: uma questão de ética e cidadania

Este artigo é o resultado de um esforço para conceituar inclusão digital, feito pelo Grupo de Estudos em Políticas de Informação e Inclusão Digital (Gepindi), vinculado ao Programa de Pós-graduação em Ciência da Informação, do Instituto de Ciência da Informação, da Universidade Federal da Bahia (Posici/ICI/UFBA). O texto discute inclusão digital à luz de outros conceitos encontrados na ciência da informação e em áreas correlatas. No imbricado entrelaçamento desses conceitos complexos, o resultado final pretendido é um marco de compreensão para a vinculação entre ética e cidadania, de um lado, e educação para a informação na Internet ou information literacy education, de outro, com vistas à inclusão social.

Guidelines for Cleaning up Former Methamphetamine Labs, June 2009

Methamphetamine (meth) drug labs are not a new hazard to Iowa. In 2004, federal, state and local authorities seized more than 1,400 Iowa labs. These labs are discovered in houses, apartments, motel rooms, motor vehicles, and even an occasional combine. A dramatic decrease in the number of meth labs occurred in 2005 when a law restricting the purchase of pseudo-ephedrine was implemented. Although the number of meth labs has decreased, they continue to exist. Since there is currently no official federal guidance or regulations on how to clean up a former meth lab, the Iowa Department of Public Health, Division of Environmental Health, has created these basic guidelines to assist public health officials, property owners and the general public in cleaning up former meth lab properties.

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.

In 2005, several groups, including the European Group for Blood and Marrow Transplantation, the European Organization for Treatment and Research of Cancer, the European Leukemia Net and the Immunocompromised Host Society created the European Conference on Infections in Leukemia (ECIL). The main goal of ECIL is to elaborate guidelines, or recommendations, for the management of infections in leukemia and stem cell transplant patients. The first sets of ECIL slides about the management of invasive fungal disease were made available on the web in 2006 and the papers were published in 2007. The third meeting of the group (ECIL 3) was held in September 2009 and the group updated its previous recommendations. The goal of this paper is to summarize the new proposals from ECIL 3, based on the results of studies published after the ECIL 2 meeting: (1) the prophylactic recommendations for hematopoietic stem cell transplant recipients were formulated differently, by splitting the neutropenic and the GVHD phases and taking into account recent data on voriconazole; (2) micafungin was introduced as an alternative drug for empirical antifungal therapy; (3) although several studies were published on preemptive antifungal approaches in neutropenic patients, the group decided not to propose any recommendation, as the only randomized study comparing an empirical versus a preemptive approach showed a significant excess of fungal disease in the preemptive group.

Evaluation of Iowa’s 70 mph Speed Limit — 2.5 Year Update, 2009

On July 1, 2005, the State of Iowa implemented a 70 mile per hour (mph) speed limit on most rural Interstates. This document reports on a study of the safety effect of this change. Changes in speeds, traffic volume on and off the rural Interstate system (diversion), and safety (crashes) for on- and off-system roads were studied. After the change, mean and 85th percentile speeds increased by about 2 mph on rural Interstates, but speeding was reduced (the number of drivers exceeding the speed limit by 10 mph decreased from 20 per cent to about 8 per cent). Daytime and nighttime serious crashes were studied for a period of 14 and a half years prior to the change and 2 and a half years afterwards. Simple descriptive statistics reveal increases in all crash severity categories for the 2 and a half year period following the speed limit increase when compared to the most recent comparable 2 and a half year period prior to the increase. When compared to longer term trends, the increases were less pronounced in some severity levels and types, and for a few severity levels the average crash frequencies were observed to decrease. However, fatal and other serious cross-median crashes increased by relatively larger amounts as compared to expected random variation. The study also analyzed crash frequencies grouped into six-month periods, revealing similar findings.

Intégrer le genre dans la formation médicale prégraduée: peut-on transférer l'expérience néerlandaise sur sol suisse ? Etude exploratoire menée au sein de l'École de médecine de l'Université de Lausanne (FBM/UNIL) pour l'année académique 2009-2010

[Table des matières] Résumé. Zusammenfassung. 1. Introduction. 2. Intégrer le genre dans les études de médecine : la " Success Story " néerlandaise. 2.1 En amont du projet national de 2002-2005. 2.1.1 L'étude pilote menée à l'Université Radboud à la fin des années 1990. 2.2 Integrating Gender into the Core Curriculum: le déroulement du projet national (2002-2005). 3. Enseignement prégradué en médecine à Lausanne: quelle place pour le genre ? Etat des lieux pour l'année académique 2009-2010. 3.1 Inventaire: quelques fleurs dans le désert ? 3.2 La situation lausannoise à l'aune des exigences du projet néerlandais. 3.3 L'organisation de l'enseignement à l'École de médecine de Lausanne suite à la réforme des années 2000. 3.4 Le développement des études genre à l'Université de Lausanne et en Suisse: quel impact sur la médecine ? 4. Inclure le genre dans les études prégraduées de médecine : le cadre au niveau suisse. 4.1 Quelles possibilités de soutien au niveau des instruments nationaux de pilotage de la formation médicale prégraduée ? 5. Quelles possibilités de transfert ? Des questions pour l'avenir. 5.1 Comment transférer l'expérience néerlandaise? 5.2 Quelles activités pourraient être entreprises au niveau national ? 6. Annexes.

Burden of Diabetes in Iowa 1991-2009, Final Report, May 2010

The Iowa Diabetes Prevention and Control Program provides educational opportunities for health care providers via the Iowa Communications Network interactive fiber optic system. The program also certifies diabetes outpatient education programs in Iowa based on minimum criteria for quality programs. In Iowa during the past 20 years, the prevalence rate of diagnosed diabetes increased dramatically among adults: Between 1991 and 2009 the crude diabetes prevalence rate rose by 84%, from 3.8% to 7.0%. Between these years, the age‐adjusted adult diagnosed diabetes prevalence rate increased by 64%, rising from 3.7% to 6.4%. During the 18 years 1991‐93 through 2006‐08, the number of Iowa adults with diagnosed diabetes more than doubled, increasing from 78,000 to 162,000. While the Iowa Behavioral Risk Factor Surveillance System (BRFSS), upon which the numbers cited above are based, provides reliable state‐level self‐reported data on adults with diagnosed diabetes, it is unable to provide estimates of undiagnosed diabetes. National estimates put the prevalence of undiagnosed adult diabetes at about 5%, raising the estimated adult diabetes prevalence rate in Iowa to 12% (280,000 adults) (Cowie,2009). Another 5% of all Iowa adults are estimated to have diagnosed pre‐diabetes, while 25% of all Iowa adults, based on national estimates from the 2005‐06 National Health and Nutrition and Examination Survey (NHANES), likely have undiagnosed pre‐diabetes. (Cowie, 2009)

Dissecting the compression of mortality in Switzerland, 1876-2005

This paper aims to examine changes in common longevity and variability of the adult life span, and attempts to answer whether or not the compression of mortality continues in Switzerland in the years 1876-2005. The results show that the negative relationships between the large increase in the adult modal age at death, observed at least from the 1920s, and the decrease in the standard deviation of the ages at deaths occurring above it, illustrate a significant compression of adult mortality. Typical adult longevity increased by about 10% during the last fifty years in Switzerland, and adult heterogeneity in the age at death decreased in the same proportion. This analysis has not found any evidence suggesting that we are approaching longevity limits in term of modal or even maximum life spans. It ascertains a slowdown in the reduction of adult heterogeneity in longevity, already observed in Japan and other low mortality countries.

Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.

BACKGROUND: Adverse effects of combination antiretroviral therapy (CART) commonly result in treatment modification and poor adherence. METHODS: We investigated predictors of toxicity-related treatment modification during the first year of CART in 1318 antiretroviral-naive human immunodeficiency virus (HIV)-infected individuals from the Swiss HIV Cohort Study who began treatment between January 1, 2005, and June 30, 2008. RESULTS: The total rate of treatment modification was 41.5 (95% confidence interval [CI], 37.6-45.8) per 100 person-years. Of these, switches or discontinuations because of drug toxicity occurred at a rate of 22.4 (95% CI, 19.5-25.6) per 100 person-years. The most frequent toxic effects were gastrointestinal tract intolerance (28.9%), hypersensitivity (18.3%), central nervous system adverse events (17.3%), and hepatic events (11.5%). In the multivariate analysis, combined zidovudine and lamivudine (hazard ratio [HR], 2.71 [95% CI, 1.95-3.83]; P < .001), nevirapine (1.95 [1.01-3.81]; P = .050), comedication for an opportunistic infection (2.24 [1.19-4.21]; P = .01), advanced age (1.21 [1.03-1.40] per 10-year increase; P = .02), female sex (1.68 [1.14-2.48]; P = .009), nonwhite ethnicity (1.71 [1.18-2.47]; P = .005), higher baseline CD4 cell count (1.19 [1.10-1.28] per 100/microL increase; P < .001), and HIV-RNA of more than 5.0 log(10) copies/mL (1.47 [1.10-1.97]; P = .009) were associated with higher rates of treatment modification. Almost 90% of individuals with treatment-limiting toxic effects were switched to a new regimen, and 85% achieved virologic suppression to less than 50 copies/mL at 12 months compared with 87% of those continuing CART (P = .56). CONCLUSIONS: Drug toxicity remains a frequent reason for treatment modification; however, it does not affect treatment success. Close monitoring and management of adverse effects and drug-drug interactions are crucial for the durability of CART.

Anàlisi “shift share” de l’evolució del cens de porcí a Espanya (1962-2005)

El desenvolupament de la ramaderia intensiva s’ha produït mitjançant aglomeracions espacials de les explotacions ramaderes. El sector porcí és un dels principals exponents d’aquesta aglomeració i concentració espacial. Per això s'ha realitzat el present PFC amb l'objectiu d'estudiar el procés de concentració de la producció porcina a les diferents Comunitats Autònomes entre els anys 1962 i 2005, investigant els efectes diferencials i d’assignació de l’anàlisi “shift share”. Es conclou que en els anys estudiats hi ha hagut dos pols d'aglomeració de la cabana porcina, Catalunya+Osca i la Regió de Múrcia, que han estat cabdals en l'abastiment dels mercats.

100 casos de derecho de daños (2004-2009)

InDret presenta, por sexto año consecutivo, una selección de veinte sentencias sobre responsabilidad civil dictadas por el Tribunal Supremo que tratan cuestiones centrales del derecho de daños. El lector también encontrará en este trabajo las selecciones de 2004, 2005, 2006, 2007 y 2008 publicadas en números anteriores.

Global surveillance of cancer survival 1995-2009 : analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75 000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems. FUNDING: Canadian Partnership Against Cancer (Toronto, Canada), Cancer Focus Northern Ireland (Belfast, UK), Cancer Institute New South Wales (Sydney, Australia), Cancer Research UK (London, UK), Centers for Disease Control and Prevention (Atlanta, GA, USA), Swiss Re (London, UK), Swiss Cancer Research foundation (Bern, Switzerland), Swiss Cancer League (Bern, Switzerland), and University of Kentucky (Lexington, KY, USA).

O perfil Brasileiro de propriedade intelectual em radiologia e diagnóstico por imagem em um contexto internacional, nos anos 2000-2009

OBJETIVO: Analisar a inovação tecnológica brasileira na área de radiologia e diagnóstico por imagem, em termos de indicadores de patentes. MATERIAIS E MÉTODOS: Este é um estudo analítico-exploratório de informações recuperadas por meio de consultas cruzadas nas bases de dados dos escritórios de propriedade intelectual do Brasil (Instituto Nacional da Propriedade Industrial - INPI), dos Estados Unidos (United States Patent and Trademark Office - USPTO) e da Europa (European Patent Office - EPO). RESULTADOS: Foram encontradas 277.057 patentes. Desse total, 7.800 foram registradas no INPI (3%), 65.428 (24%) registradas no EPO e 203.829 (73%) emitidas no USPTO. O Brasil é o país signatário em 1.732 patentes publicadas no INPI, 80 no EPO e 26 no escritório USPTO. Globalmente, 219.993 (79%) patentes referiam-se a dispositivos eletrônicos ligados a informática em saúde, ultrassonografia, ressonância magnética, tomografia computadorizada e procedimentos de geração, comunicação e arquivamento de imagens, e 57.064 (21%) das patentes tratavam das tecnologias relacionadas a radioproteção e dosimetria, física nuclear, eletroterapia, terapia magnética e radioterapia. CONCLUSÃO: Os resultados obtidos apontam para a fragilidade da produção nacional de inovação tecnológica registrada em patentes, no campo de radiologia e diagnóstico por Imagem.

Julkisten osakeyhtiöiden toimintakertomustietojen kehittyminen ajalla 2005-2008

Tutkimuksen tavoitteena on identifioida julkisten osakeyhtiöiden toimintakertomusta säätelevien normien muutokset vuosien 2005 ja 2008 välillä. Tutkimuksessa kartoitetaan sisältyvätkö kaikki normien edellyttämät tiedot yhtiöiden vuodelta 2008 julkistettuihin toimintakertomuksiin, esiintyykö puutteita joidenkin tiettyjen tietovaatimusten osalta, esiintyykö yhtiöiden toimintakertomuksissa selkeitä laadullisia eroja ja ovatko yhtiöt esittäneet vapaaehtoisesti joitain tietoja jo vuoden 2005 toimintakertomuksissa. Tutkimusaineiston muodostavat Helsingin pörssissä noteerattujen markkinaarvoltaan pienten ja suurten suomalaisten julkisten osakeyhtiöiden toimintakertomukset vuosilta 2005 ja 2008. Tutkimus on laadullinen kuvaileva tapaustutkimus, jolla pyritään keräämään yksityiskohtaista, intensiivistä tietoa sekä suomalaisten julkisten osakeyhtiöiden toimintakertomuksiin kohdistuvista normistomuutoksista tarkastelujaksolla että laadullisista eroavaisuuksista yhtiöiden toimintakertomusten välillä. Tulosten perusteella voidaan todeta, että suomalaisten julkisten osakeyhtiöiden toimintakertomuksissa esiintyy edelleen puutteita, vaikka tarkastelujaksolla oli tapahtunut myös selvää parannusta. Toimintakertomuksissa esiintyi selviä yhtiökohtaisia eroavaisuuksia, mutta selkeää eroa ei havaittu pienten ja suurten yhtiöiden toimintakertomusten välillä.

Lounais-Suomen meriklusteri 2009

Lounais-Suomen meriklusteri kattaa Varsinais-Suomen ja Satakunnan maakunnat. Ensimmäinen alueellisen meriklusterin perusselvitys valmistui vuonna 2006. Tämän tutkimusraportin pääsisältönä on Lounais-Suomen meriklusterin taloudellisten ja toiminnallisten perustunnuslukujen päivitys sekä niiden esittäminen aikasarjana vuodesta 2005 vuoteen 2008. Tilastollisen aineiston perusvuosi on 2008. Varsinais-Suomessa ja Satakunnassa toimii vajaat 340 meriklusteriin kuuluvaa yritystä, joilla on alueella noin 400 toimipaikkaa. Näistä Satakunnassa sijaitsee reilut 100 ja Varsinais-Suomessa vajaat 300. Määrä on hieman pienempi kuin perusselvityksen aikaan, mikä johtuu osin yritysfuusioista ja osin siitä, että jotkut yritykset eivät enää toimi merisektorilla. Meriklusterin merkitys on edelleen erittäin suuri Lounais-Suomessa ja sen suhteellinen osuus on säilynyt samassa suuruusluokassa kuin vuonna 2006. Meriklusteriyritysten Lounais-Suomen toimipaikkojen yhteenlaskettu liikevaihto vuonna 2008 oli noin 4,3 miljardia euroa, josta noin 3,5 miljardia euroa tuli suoraan yritysten merisektorin liiketoiminnasta. Meriklusteriyritykset työllistävät alueella yhteensä noin 17 000 henkilöä, joista merisektori työllistää suoraan noin 12 700 henkilöä. Meriklusterin osuus kaikista Varsinais-Suomen ja Satakunnan työllisistä on noin 5,4 prosenttia. Välilliset työllisyysvaikutukset huomioiden meriklusteri työllistää Lounais-Suomessa vähintään 27 000 henkilöä eli noin 8,2 prosenttia alueen työllisistä. Lounais-Suomen osuus koko Suomen meriklusterista vaihtelee eri pääryhmittäin. Liikevaihdon mukaan mitattuna telakkatoiminnassa osuus on noin 85 prosenttia, varustamotoiminnassa noin 15 prosenttia ja satamissa noin 25 prosenttia. Karkeasti arvioituna kaikkien meriklusteriyritysten merisektorin toimintojen osalta Lounais-Suomen toimipaikkojen liikevaihdon osuus on noin 30–40 prosenttia. Aikasarjatarkastelu osoittaa, että meriklusterin positiivinen kehitys taittui vuonna 2008. Liikevaihdon kasvu hiipui, kuten myös henkilöstömäärän kasvu. Elo-syyskuun 2009 tilanne osoittaa, että henkilöstömäärä on laskenut edellisestä vuodesta. Kyselyyn vastanneista yrityksistä lähes kolmannes oli jo joutunut lomauttamaan henkilöstöään. Liiketoiminnan tulevaisuudennäkymät ovat nyt huomattavasti synkemmät kuin vuonna 2006. Vain hieman yli 10 prosenttia vastaajista arvioi näkymien parantuvan tulevan vuoden sisällä. Hieman yli puolet odottaa tilanteen säilyvän ennallaan ja lähes 30 prosenttia uskoo näkymien edelleen heikkenevän. Meriteollisuuden näkymät ovat kaikkein huonoimmat ja näkymiä leimaavat monet erityyppiset epävarmuustekijät. Merikuljetukset ja satamatoiminnot puolestaan ovat suoraan riippuvaisia yleisestä taloudellisesta tilanteesta ja siinä tapahtuvat muutokset heijastuvat niihin varsin nopeasti.